Is migraine a lateralization defect?

NeuroReport

Volumn 19, Issue 13, 2008, Pages 1351-1353

  Kaaro, Jani ^a   Partonen, Timo ^b   Naik, Paulami ^c   Hadjikhani, Nouchine ^c,d,e  

^a AV Torppa Oy ^*  (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d HARVARD MIT DIVISION OF HEALTH SCIENCES AND TECHNOLOGY   (United States)

^e EPFL   (Switzerland)

Author keywords

Development; Lateralization; Migraine; Pinealgland; Serotonin

Indexed keywords

SEROTONIN;

ADULT; ARTICLE; BRAIN SCINTISCANNING; CIRCADIAN RHYTHM; CONTROLLED STUDY; DISEASE ASSOCIATION; EMBRYO DEVELOPMENT; FEMALE; HEMISPHERIC DOMINANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIGRAINE; PATENT FORAMEN OVALE; PINEAL BODY; PRIORITY JOURNAL; REGULATORY MECHANISM; SEROTONIN RELEASE; BRAIN; CONGENITAL MALFORMATION; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; RADIOGRAPHY; RISK FACTOR;

ADULT; BRAIN; FEMALE; FORAMEN OVALE, PATENT; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MIGRAINE DISORDERS; PINEAL GLAND; RISK FACTORS;

EID: 52649093880     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/WNR.0b013e32830c4698     Document Type: Article

References (26)

1. Del Sette M, Angeli S, Leandri M, Ferriero G, Bruzzone GL, Finocchi C, et al. Migraine with aura and right-to-left shunt on transcranial Doppler: a case-control study. Cerebrovasc Dis 1998; 8:327-330.
2. Wilmshurst PT, Nightingale S, Walsh KP, Morrison WL. Effect on migraine of closure of cardiac right-to-left shunts to prevent recurrence of decompression illness or stroke or for haemodynamic reasons. Lancet 2000; 356:1648-1651.
3. Tepper SJ, Sheftell FD, Bigal ME. The patent foramen ovale-migraine question. Neurol Sci 2007; 28 (Suppl 2):S118-S123.
4. Kruit MC, van Buchem MA, Hofman PA, Bakkers JT, Terwindt GM, Ferrari MD, et al. Migraine as a risk factor for subclinical brain lesions. J Am Med Assoc 2004; 291:427-434.
5. Gillis CN, Pitt BR. The fate of circulating amines within the pulmonary circulation. Annu Rev Physiol 1982; 44:269-281.
6. Bar-Oz B, Einarson T, Einarson A, Boskovic R, O'Brien L, Malm H, et al. Paroxetine and congenital malformations: meta-analysis and consideration of potential confounding factors. Clin Ther 2007; 29: 918-926.
7. Louik C, Lin AE, Werler MM, Hernandez-Diaz S, Mitchell AA. Firsttrimester use of selective serotonin-reuptake inhibitors and the risk of birth defects. N Engl J Med 2007; 356:2675-2683.
8. Gaio U, Schweickert A, Fischer A, Garratt AN, Muller T, Ozcelik C, et al. A role of the cryptic gene in the correct establishment of the left-right axis. Curr Biol 1999; 9:1339-1342.
9. Kathiriya IS, Srivastava D. Left-right asymmetry and cardiac looping: implications for cardiac development and congenital heart disease. Am J Med Genet 2000; 97:271-279.
10. Fukumoto T, Kema IP, Levin M. Serotonin signaling is a very early step in patterning of the left-right axis in chick and frog embryos. Curr Biol 2005; 15:794-803.
11. Liang JO, Etheridge A, Hantsoo L, Rubinstein AL, Nowak SJ, Izpisua Belmonte JC, et al. Asymmetric nodal signaling in the zebrafish diencephalon positions the pineal organ. Development (Cambridge, England) 2000; 127:5101-5112.
12. McIntyre RS, Konarski JZ, Wilkins K, Bouffard B, Soczynska JK, Kennedy SH. The prevalence and impact of migraine headache in bipolar disorder: results from the Canadian Community Health Survey. Headache 2006; 46:973-982.
13. Dalla Volta G, Guindani M, Zavarise P, Griffini S, Pezzini A, Padovani A. Prevalence of patent foramen ovale in a large series of patients with migraine with aura, migraine without aura and cluster headache, and relationship with clinical phenotype. J Headache Pain 2005; 6:328-330.
14. Shepherd AJ. Colour vision in migraine: selective deficits for S-cone discriminations. Cephalalgia 2005; 25:412-423.
15. Wright HR, Lack LC. Effect of light wavelength on suppression and phase delay of the melatonin rhythm. Chronobiol Int 2001; 18:801-808.
16. Lambert GW, Reid C, Kaye DM, Jennings GL, Esler MD. Effect of sunlight and season on serotonin turnover in the brain. Lancet 2002; 360:1840-1842.
17. Lewy AJ, Wehr TA, Goodwin FK, Newsome DA, Markey SP. Light suppresses melatonin secretion in humans. Science 1980; 210:1267-1269.
18. Schuh-Hofer S, Richter M, Geworski L, Villringer A, Israel H, Wenzel R, et al. Increased serotonin transporter availability in the brainstem of migraineurs. J Neurol 2007; 254:789-796.
19. Hamel E. Serotonin and migraine: biology and clinical implications. Cephalalgia 2007; 27:1293-1300.
20. Claustrat B, Loisy C, Brun J, Beorchia S, Arnaud JL, Chazot G. Nocturnal plasma melatonin levels in migraine: a preliminary report. Headache 1989; 29:242-245.
21. McLean AB, D'Amour KA, Jones KL, Krishnamoorthy M, Kulik MJ, Reynolds DM, et al. Activin a efficiently specifies definitive endoderm from human embryonic stem cells only when phosphatidylinositol 3-kinase signaling is suppressed. Stem cells (Dayton, Ohio) 2007; 25:29-38.
22. Ahn AH, Basbaum AI. Where do triptans act in the treatment of migraine? Pain 2005; 115:1-4.
23. Shields KG, Goadsby PJ. Serotonin receptors modulate trigeminovascular responses in ventroposteromedial nucleus of thalamus: a migraine target? Neurobiol Dis 2006; 23:491-501.
24. Hadjikhani N, Sanchez del Rio M, Wu O, Schwartz D, Bakker D, Fischl B, et al. Mechanisms of migraine aura revealed by functional MRI in human visual cortex. Proc Natl Acad Sci U S A 2001; 98:4687-4692.
25. Richter F, Mikulik O, Ebersberger A, Schaible HG. Noradrenergic agonists and antagonists influence migration of cortical spreading depression in rat-a possible mechanism of migraine prophylaxis and prevention of postischemic neuronal damage. J Cereb Blood Flow Metab 2005; 25:1225-1235.
26. Hanoun N, Saurini F, Lanfumey L, Hamon M, Bourgoin S. Dihydroergotamine and its metabolite, 8'-hydroxy-dihydroergotamine, as 5-HT1A receptor agonists in the rat brain. Br J Pharmacol 2003; 139: 424-434.